Sfoglia per Autore
Evidence of polymorphic CYP2C19 involvement in the human metabolism of N-desmethylclobazam
2002 Contin M.; Sangiorgi Simonetta; Riva Roberto; Parmeggiani Antonia; Albani Fiorenzo; Baruzzi Agostino
Drug rash with eosinophilia and systemic symptoms secondary to phenobarbitone
2003 Baruzzi A.; Contin M.; Barbara G.; Cremon C.; De Giorgio R.; Patrizi A.; Albani F.; Corinaldesi R.
Un anno di follow-up nei pazienti con epilessia parziale che hanno completato il passaggio da carbamazepina a excarbazepina.
2004 Albani F; Baruzzi A; Gruppo di Studio "Follow-up Studio PRIMO.
Levetiracetam therapeutic monitoring in patients with epilepsy: effect of concomitant antiepileptic drugs.
2004 CONTIN M; ALBANI F; RIVA R; BARUZZI A.
Dopamine transporter gene polymorphism, spect imaging, and levodopa response in patients with Parkinson disease.
2004 CONTIN M; MARTINELLI P; MOCHI M; ALBANI F; RIVA R; SCAGLIONE C; DONDI M; FANTI S; PETTINATO C; BARUZZI A.
Il monitoraggio terapeutico dell’oxcarbazepina nella terapia dell’Epilessia
2004 Albani F.
Immediate (overnight) switching from carbamazepine to oxcarbazepine monotherapy is equivalent to a progressive switch.
2004 ALBANI F; GRASSI B; FERRARA R; TURRINI R; BARUZZI A.; PRIMO STUDY GROUP.
Simultaneous liquid chromatographic determination of lamotrigine, oxcarbazepine monohydroxy derivative and felbamate in plasma of patients with epilepsy
2005 Contin M; Balboni M; Callegati E; Candela C; Albani F; Riva R; Baruzzi A
Genetic polymorphism of catechol-O-methyltransferase and levodopa pharmacokinetic-pharmacodynamic pattern in patients with Parkinson's disease.
2005 Contin M; Martinelli P; Mochi M; Riva R; Albani F; Baruzzi A.
A pilot double-blind placebo-controlled trial of low-dose pramipexole in sleep-related eating disorder.
2005 Provini F.; Albani F.; Vetrugno R.; Vignatelli L.; Lombardi C.; Plazzi G.; Montagna P.
Levetiracetam therapy in patients with brain tumour and epilepsy
2006 Maschio M.; Albani F.; Baruzzi A.; Zarabla A.; Dinapoli L.; Pace A.; Pompili A.; Carapella C.M.; Occhipinti E.; Jandolo B.
Recommendations of the italian league against epilepsy working group on generic products of antiepileptic drugs
2006 Perucca E.; Albani F.; Capovilla G.; Della Bernardina B.; Michelucci R.; Zaccara G.
Oxcarbazepine long-term treatment retention in patients switched over from carbamazepine
2006 Albani F.; Baruzzi A.; Antonini L.; De Maria G.; Avanzini G.; Basso P.; Bettini B.; Bisulli F.; Consoli D.; D’Alessandro P. ; Garofalo P. ; P. Murri P. ; Muscas G.; Musumeci S.; Paggi A.; Passarella B.; Striano S.; Zucca C.
Variation in Lamotrigine Plasma Concentrations with Hormonal Contraceptive Monthly Cycles in Patients with Epilepsy
2006 Contin M.; Albani F.; Ambrosetto G.; Avoni P.; Bisulli F.; Riva R.; Tinuper P.; Baruzzi A.
Il monitoraggio terapeutico dei farmaci antiepilettici
2007 F. Albani; M. Contin; R. Riva; A. Baruzzi.
Kinetic-dynamic monitoring of levetiracetam effects in patients with Parkinson disease and levodopa-induced dyskinesias.
2007 Contin M.; Martinelli P.; Albani F.; Scaglione C.; Avoni P.; Rizzo G.; Baruzzi A.
Multicentre observational study evaluating immediate and progressive switching from carbamazepine to oxcarbazepine in patients with epilepsy.
2007 Albani F.; Bisulli F.; Bartezaghi M.; Turrini R.; Baruzzi A.; and SECONDO Study Group.
Treatment of narcolepsy with cataplexy.
2007 Plazzi G.; Montagna P.; Provini F.; Albani F.; Riva R.
The effect of entacapone on levodopa rate of absorption and latency to motor response in patients with Parkinson disease.
2008 Contin M.; Martinelli P.; Scaglione C.; Avoni P.; Albani F.; Riva R.; Baruzzi A.
Temozolomide treatment does not affect topiramate and oxcarbazepine plasma concentrations in chronically treated patients with brain tumor-related epilepsy.
2008 Maschio M.; Albani F.; Jandolo B.; Zarabla A.; Contin M.; Dinapoli L.; Fabi A.; Pace A.; Baruzzi A.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Evidence of polymorphic CYP2C19 involvement in the human metabolism of N-desmethylclobazam | Contin M.; Sangiorgi Simonetta; Riva Roberto; Parmeggiani Antonia; Albani Fiorenzo; Baruzzi Agostino | 2002-01-01 | THERAPEUTIC DRUG MONITORING | - | 1.01 Articolo in rivista | - |
| Drug rash with eosinophilia and systemic symptoms secondary to phenobarbitone | Baruzzi A.; Contin M.; Barbara G.; Cremon C.; De Giorgio R.; Patrizi A.; Albani F.; Corinaldesi R. | 2003-01-01 | CLINICAL NEUROPHARMACOLOGY | - | 1.01 Articolo in rivista | - |
| Un anno di follow-up nei pazienti con epilessia parziale che hanno completato il passaggio da carbamazepina a excarbazepina. | Albani F; Baruzzi A; Gruppo di Studio "Follow-up Studio PRIMO. | 2004-01-01 | BOLLETTINO-LEGA ITALIANA CONTRO L'EPILESSIA | - | 1.01 Articolo in rivista | - |
| Levetiracetam therapeutic monitoring in patients with epilepsy: effect of concomitant antiepileptic drugs. | CONTIN M; ALBANI F; RIVA R; BARUZZI A. | 2004-01-01 | THERAPEUTIC DRUG MONITORING | - | 1.01 Articolo in rivista | - |
| Dopamine transporter gene polymorphism, spect imaging, and levodopa response in patients with Parkinson disease. | CONTIN M; MARTINELLI P; MOCHI M; ALBANI F; RIVA R; SCAGLIONE C; DONDI M; FANTI S; PETTINATO C; BA...RUZZI A. | 2004-01-01 | CLINICAL NEUROPHARMACOLOGY | - | 1.01 Articolo in rivista | - |
| Il monitoraggio terapeutico dell’oxcarbazepina nella terapia dell’Epilessia | Albani F. | 2004-01-01 | - | Springer | 3.01 Monografia / trattato scientifico in forma di libro | - |
| Immediate (overnight) switching from carbamazepine to oxcarbazepine monotherapy is equivalent to a progressive switch. | ALBANI F; GRASSI B; FERRARA R; TURRINI R; BARUZZI A.; PRIMO STUDY GROUP. | 2004-01-01 | SEIZURE | - | 1.01 Articolo in rivista | - |
| Simultaneous liquid chromatographic determination of lamotrigine, oxcarbazepine monohydroxy derivative and felbamate in plasma of patients with epilepsy | Contin M; Balboni M; Callegati E; Candela C; Albani F; Riva R; Baruzzi A | 2005-01-01 | JOURNAL OF CHROMATOGRAPHY. B | - | 1.01 Articolo in rivista | - |
| Genetic polymorphism of catechol-O-methyltransferase and levodopa pharmacokinetic-pharmacodynamic pattern in patients with Parkinson's disease. | Contin M; Martinelli P; Mochi M; Riva R; Albani F; Baruzzi A. | 2005-01-01 | MOVEMENT DISORDERS | - | 1.01 Articolo in rivista | - |
| A pilot double-blind placebo-controlled trial of low-dose pramipexole in sleep-related eating disorder. | Provini F.; Albani F.; Vetrugno R.; Vignatelli L.; Lombardi C.; Plazzi G.; Montagna P. | 2005-01-01 | EUROPEAN JOURNAL OF NEUROLOGY | - | 1.01 Articolo in rivista | - |
| Levetiracetam therapy in patients with brain tumour and epilepsy | Maschio M.; Albani F.; Baruzzi A.; Zarabla A.; Dinapoli L.; Pace A.; Pompili A.; Carapella C.M.; ...Occhipinti E.; Jandolo B. | 2006-01-01 | JOURNAL OF NEURO-ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Recommendations of the italian league against epilepsy working group on generic products of antiepileptic drugs | Perucca E.; Albani F.; Capovilla G.; Della Bernardina B.; Michelucci R.; Zaccara G. | 2006-01-01 | EPILEPSIA | - | 1.01 Articolo in rivista | - |
| Oxcarbazepine long-term treatment retention in patients switched over from carbamazepine | Albani F.; Baruzzi A.; Antonini L.; De Maria G.; Avanzini G.; Basso P.; Bettini B.; Bisulli F.; C...onsoli D.; D’Alessandro P. ; Garofalo P. ; P. Murri P. ; Muscas G.; Musumeci S.; Paggi A.; Passarella B.; Striano S.; Zucca C. | 2006-01-01 | NEUROLOGICAL SCIENCES | - | 1.01 Articolo in rivista | - |
| Variation in Lamotrigine Plasma Concentrations with Hormonal Contraceptive Monthly Cycles in Patients with Epilepsy | Contin M.; Albani F.; Ambrosetto G.; Avoni P.; Bisulli F.; Riva R.; Tinuper P.; Baruzzi A. | 2006-01-01 | EPILEPSIA | - | 1.01 Articolo in rivista | - |
| Il monitoraggio terapeutico dei farmaci antiepilettici | F. Albani; M. Contin; R. Riva; A. Baruzzi. | 2007-01-01 | LA RIVISTA ITALIANA DELLA MEDICINA DI LABORATORIO | - | 1.01 Articolo in rivista | - |
| Kinetic-dynamic monitoring of levetiracetam effects in patients with Parkinson disease and levodopa-induced dyskinesias. | Contin M.; Martinelli P.; Albani F.; Scaglione C.; Avoni P.; Rizzo G.; Baruzzi A. | 2007-01-01 | CLINICAL NEUROPHARMACOLOGY | - | 1.04 Replica / breve intervento (e simili) | - |
| Multicentre observational study evaluating immediate and progressive switching from carbamazepine to oxcarbazepine in patients with epilepsy. | Albani F.; Bisulli F.; Bartezaghi M.; Turrini R.; Baruzzi A.; and SECONDO Study Group. | 2007-01-01 | FUNCTIONAL NEUROLOGY | - | 1.01 Articolo in rivista | - |
| Treatment of narcolepsy with cataplexy. | Plazzi G.; Montagna P.; Provini F.; Albani F.; Riva R. | 2007-01-01 | THE LANCET | - | 1.01 Articolo in rivista | - |
| The effect of entacapone on levodopa rate of absorption and latency to motor response in patients with Parkinson disease. | Contin M.; Martinelli P.; Scaglione C.; Avoni P.; Albani F.; Riva R.; Baruzzi A. | 2008-01-01 | CLINICAL NEUROPHARMACOLOGY | - | 1.01 Articolo in rivista | - |
| Temozolomide treatment does not affect topiramate and oxcarbazepine plasma concentrations in chronically treated patients with brain tumor-related epilepsy. | Maschio M.; Albani F.; Jandolo B.; Zarabla A.; Contin M.; Dinapoli L.; Fabi A.; Pace A.; Baruzzi A. | 2008-01-01 | JOURNAL OF NEURO-ONCOLOGY | - | 1.01 Articolo in rivista | - |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile